✦ LIBER ✦

Enhanced induction of lymphokine-activated killer activity after lentinan administration in patients with gastric carcinoma

✍ Scribed by Shinya Arinaga; Nobuya Karimine; Kiyoshi Takamuku; Shigeru Nanbara; Hiroshi Inoue; Masaaki Nagamatsu; Hiroaki Ueo; Tsuyoshi Akiyoshi

Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 346 KB
Volume: 14
Category: Article
ISSN: 0192-0561
DOI: 10.1016/0192-0561(92)90114-z

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The effect of lentinan on natural killer

The effect of lentinan on natural killer activities in patients with gastric carcinoma and normal controls

✍ H. Yamanishi; H. Nagai; K. Miura; K. Ina; S. Suga 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Enhanced induction of lymphokine-activat

Enhanced induction of lymphokine-activated killer activity following a single dose of cisplatin in cancer patients

✍ Shinya Arinaga; Masashi Adachi; Nobuya Karimine; Hiroshi Inoue; Tsukasa Asoh; Hi 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Lymphokine-activated killer cell functio

Lymphokine-activated killer cell function of lymphocytes from regional lymph nodes in patients with gastric carcinoma

✍ Shinya Arinaga; Nobuya Karimine; Shigeru Nanbara; Hiroshi Inoue; Hideaki Nakashi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

Lymphokine-activated killer (LAK) cells generated by culture of regional lymph node cells (LNC) with interleukin 2 (IL 2) for 4 and 11 days were examined for their functional capabilities in comparison with those of peripheral blood mononuclear cells (PBM) in 25 patients with gastric carcinoma. The

Enhanced production of interleukin 1 and

Enhanced production of interleukin 1 and tumor necrosis factor by peripheral monocytes after lentinan administration in patients with gastric carcinoma

✍ Shinya Arinaga; Nobuya Karimine; Kiyoshi Takamuku; Shigeru Nanbara; Masaaki Naga 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 340 KB

Assessment of lymphokine-activated kille

Assessment of lymphokine-activated killer activity and γ-interferon production in patients with small hepatocellular carcinomas

✍ Toshiji Saibara; Takashi Maeda; Masako Miyazaki; Saburo Onishi; Yasutake Yamamot 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 550 KB

We have previously reported depressed y-interferon production and depressed lymphokine-activated killer and natural killer activity in patients with relatively large hepatocellular carcinomas. These parameters were normal in cirrhosis. Some evidence had suggested a y-interferon production defect as

Defective function of lymphokine-activat

Defective function of lymphokine-activated killer cells and natural killer cells in patients with hepatocellular carcinoma

✍ Toshiji Saibara; Saburo Onishi; Hiroshi Sakaeda; Yasutake Yamamoto 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 608 KB

Lymphokine-activated killer activity and natural killer activity in hepatocellular carcinoma patients were d. Maximum lymphokine-activated killer activity was induced at 3 to 6 days of incubation, and lymphokine-activated killer activity tended to increase in a manner dose dependent of recombinant i